HEALTH & FITNESS
on the coveAL

Judith Doner Berne
Special to the Jewish News

T

hey've been known to help form
a Kaddish minyan in a hospital
conference room or office. They
attend weddings and bar and bat mitz-
vahs together. Their collegiality is evident
as they talk about their shared passion —
changing lives and giving hope through
neuroscience.
Drs. Manuel Brown, Stan Elias and
Mark Rosenblum and Michael Chopp,
Ph.D., head the Henry Ford Neuroscience
Institute, based at Henry Ford Hospital
in downtown Detroit. It's set to expand
to Henry Ford West Bloomfield when the
new 300-bed hospital opens next year.
"Most of what we do here will be
translated into West Bloomfield:' says
Rosenblum, who also is chair of neuro-
surgery, co-director of the Hermelin Brain
Tumor Center and was recently appointed
vice president of clinical programs at
HFH West Bloomfield.
"We are developing a 'Mayo Clinic'
at West Bloomfield;' Rosenblum says.
"Neurological disease is the most com-
mon disease in the United States when
you add up all its forms."
Detroit Jewish community's most sig-
nificant leaders and philanthropists.
Ten years ago, Henry Ford Hospital
combined eight departments to form its
Neuroscience Institute. In the institute,
as throughout the hospital, all medical
personnel work only for the Henry Ford
Health System.
"We share one medical record," says
Brown, radiology chairman. "We can
focus only on the patients, with no dis-
tractions. We can arrange for multiple
doctors to sit together over one patient.
Our model is the same as the Cleveland
and Mayo clinics."

Jewish physicians team up
to battle neurological disease.

What Is Targeted
The new facility will offer diagnosis and
treatment for spinal disorders, brain
tumors (the Hermelin Center), seizure
disorders, strokes caused by blockages
of arteries and brain bleeding, neurode-
generative disorders such as Parkinson's
Disease, Alzheimer's, multiple sclerosis,
and disorders of vision, hearing and bal-
ance, Rosenblum says.
The basic research that Chopp
heads will remain downtown, but West
Bloomfield patients will be involved in the
clinical trials it generates. Forty percent
of the institute's patients are currently
involved in clinical trials.
A new emphasis at West Bloomfield
will be a Senior Neuroscience Center
focusing directly on the area's aging
population.
"One of the big plans is a multidisci-

Tumor Fighters on page 35

January 25 2007

33

